Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
Current vaccine strategies for SARS-CoV-2 focus on eliciting neutralising antibodies to the spike protein (S), but differences in immunogenicity of full-length S versus receptor binding domain (RBD) only aren’t fully understood. Here, the authors show immunogenicity of different prime-boost strategi...
Guardado en:
Autores principales: | Hyon-Xhi Tan, Jennifer A. Juno, Wen Shi Lee, Isaac Barber-Axthelm, Hannah G. Kelly, Kathleen M. Wragg, Robyn Esterbauer, Thakshila Amarasena, Francesca L. Mordant, Kanta Subbarao, Stephen J. Kent, Adam K. Wheatley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b17f9766ef544d9a9c0b913c34a2543 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Wen Shi Lee, et al.
Publicado: (2021) -
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Adam K. Wheatley, et al.
Publicado: (2021) -
Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Yi Liu, et al.
Publicado: (2019) -
Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019) -
Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice
por: Albert To, et al.
Publicado: (2018)